Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005

Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013

Published:2023-10-27 Issue:11 Volume:46 Page:e209-e209
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Pinheiro Marcelo Maia¹^ORCID,Pinheiro Felipe Moura Maia²^ORCID

Affiliation:

1. 1UNIVAG Centro Universitário, Várzea Grande, Mato Grosso, Brazil

2. 2Hospital das Clínicas, Faculdade de Medicina de São Paulo – Universidade de São Paulo, São Paulo, SP, Brazil

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/46/11/e209/737023/dc231115.pdf

Reference5 articles.

1. Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial;Russell;Diabetes Care,2023

2. Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes;Pinheiro;Int Immunopharmacol,2021

3. Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study;Pinheiro;Arch Endocrinol Metab,2023

4. Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes;Rabinovitch;Front Endocrinol (Lausanne),2023

5. Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes;Xu;Nat Commun,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013;Diabetes Care;2023-10-27